Treatment strategies for dystonia

Bibliography

• Jankovic J. Treatment of dystonia. Lancet Neurol 2006;5:864-72
   PubMed Web of Science ®Google Scholar
• Goldman J, Comella C. Treatment Of dystonia. Clin Neuropharmacol 2003;26(2):102-8
   PubMedGoogle Scholar
• BhidayasiriR, Tarsy D. Treatment of dystonia. Expert Rev Neurother 2006;6(6):863-86
   PubMedGoogle Scholar
• Ostrem JL, Starr PA. Treatment of dystonia with deep brain stimulation. Neurotherapeutics 2008;5(2):320-30
   PubMedGoogle Scholar
• Marks WJJ. Brain surgery for dystonia. In: Stacey MA, editor, Handbook of dystonia. Informa Healtcare Usa, Inc.: New York; 2007. p. 393-406
   Google Scholar
• Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 1986;36(2):160-4
   PubMedGoogle Scholar
• Greene P, Shale H, Fahn S. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord 1988;3(1):46-60
   PubMedGoogle Scholar
• Fahn S. High dosage anticholinergic therapy in dystonia. Neurology 1983;33(10):1255-61
   PubMedGoogle Scholar
• Tsao C. Low-dose trihexyphenidyl in the treatment of dystonia. Pediatr Neurol 1988;4:381
   PubMedGoogle Scholar
• Taylor AE, Lang AE, Saint-Cyr JA, Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies. Clin Neuropharmacol 1991;14(1):62-77
   PubMedGoogle Scholar
• Burke RE, Fahn S. Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients. Ann Neurol 1985;18:35-40
   PubMed Web of Science ®Google Scholar
• Greene P. Baclofen in the treatment of dystonia. Clin Neuropharmacol 1992;15:276-88
   PubMed Web of Science ®Google Scholar
• Greene PE, Fahn V. Baclofen in the treatment of idiopathic dystonia in children. Mov Disord 1992;7(1): 48-52
   PubMedGoogle Scholar
• Sandyk R. Blepharospasm- successful treatment with baclofen and sodium valproate. A case report. S Afr Med J 1983;64:955-6
   PubMedGoogle Scholar
• Sandyk R. Treatment of writer's cramp with sodium valproate and baclofen. A case report. S Afr Med J 1983;63:702-3
   PubMed Web of Science ®Google Scholar
• Brennan M, Ruff P, Sandyk R. Efficacy of a combination of sodium valproate and baclofen in meige's disease (idiopathic orofacial dystonia). Br Med J (Clin Res Ed). 1982 Sep 25;285(6345):853
   PubMedGoogle Scholar
• Anca MH, Zaccai TF, Badarna S, Natural history of oppenheim's dystonia (Dyt1) In Israel. J Child Neurol 2003;18:325-30
   PubMedGoogle Scholar
• Jankovic J. Medical therapy and botulinum toxin in dystonia. Adv Neurol 1998;78:169-83
   PubMedGoogle Scholar
• Hughes AJ, Lees AJ, Marsden CD. Paroxysmal dystonic head tremor. Mov Disord 1991;6(1):85-6
   PubMedGoogle Scholar
• Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983;13(4):402-11
   PubMedGoogle Scholar
• Davis TL, Charles PD, Burns RS. Clonazepam-sensitive intermittent dystonic tremor. South Med J 1995;88(10):1069-71
   PubMedGoogle Scholar
• Fletcher NA, Thompson PD, Scadding JW, Successful treatment of childhood onset symptomatic dystonia with levodopa. J Neurol Neurosurg Psychiatry 1993;56(8):865-7
   PubMedGoogle Scholar
• Barrett RE, Yahr MD, Duvoisin RC, Torsion dystonia and spasmodic torticollis- results of treatment with L-dopa. Neurology 1970;20(11):107-13
   PubMedGoogle Scholar
• Coleman M. Preliminary remarks on L-dopa therapy of dystonia. Neurology 1970;20(11):114-21
   PubMedGoogle Scholar
• Mandell S. The treatment of dystonia with L-dopa and haloperidol. Neurology 1970;20(11):103-6
   PubMedGoogle Scholar
• Greene P, Shale H, Fahn S. Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Adv Neurol 1988;50:547-56
   PubMedGoogle Scholar
• Lang AE. Dopamine agonists and antagonists in treatment of idiopathic dystonia. Adv Neurol 1988;50:561-70
   PubMedGoogle Scholar
• Jinnah HA, Hess EJ. Experimental therapeutics for dystonia. Neurotherapeutics 2008;5:198-209
   PubMed Web of Science ®Google Scholar
• Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991;41:174-81
   PubMed Web of Science ®Google Scholar
• Ichinose H, Ohye T, Takahashi E, Hereditary progressive dystonia with marked diurnal fluctuation caused by mutation in the Gtp-cyclohydrolase I gene. Nat Genet 1994;8:232-42
   Google Scholar
• Nygaard T, Wilhelmsen K, Risch N, Linkage mapping of dopa-responsive dystonia (Drd) to chromosome 14q. Nat Genet 1993;5:386-91
   PubMed Web of Science ®Google Scholar
• Steinberger D, Blau N, Goriuonov D, Heterozygous mutation in 55-untranslated region of sepiapterin reductase gene (Spr) in a patient with dopa-responsive dystonia. Neurogenetics 2004;5:187-90
   PubMedGoogle Scholar
• Steinberger D, Korinthenber R, Topka H, Dopa-responsive dystonia: mutation analysis of Gch1 and analysis of therapeutic doses of L-dopa. Neurology 2000;55:1735-37
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Graf WD, Wong H, Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (Th) gene mutations. Neurology 2001;56:260-53
   PubMed Web of Science ®Google Scholar
• Jimenez-Jimenez F, Garcia-Ruiz P, Molina J. Drug-induced movement disorders. Drug Saf 1997;16:180-204
   PubMed Web of Science ®Google Scholar
• Zuddas A, Cianchetti C. Efficacy of risperidone in idiopathic segmental dystonia. Lancet 1996;347:127-8
   PubMedGoogle Scholar
• Reeves R, Liberto V. Treatment of essential blepharospasm with quetiapine. Mov Disord 2003;18(9):1072-3
   PubMedGoogle Scholar
• Karp BI, Goldstein SR, Chen R, An open trial of clozapine for dystonia. Mov Disord 1999;14(4):652-7
   PubMedGoogle Scholar
• Burbaud P, Guehl D, Lagueny A, A pilot trial of clozapine in the treatment of cervical dystonia. J Neurol 1998;245(6-7):329-31
   PubMedGoogle Scholar
• Wolf M, Mosnaim A. Improvement of axial dystonia with the administration of clozapine. Int J Clin Pharmacol Ther 1994;32:282-3
   PubMedGoogle Scholar
• Thiel A, Dressler D, Kistel C, Clozapine treatment of spasmodic torticollis. Neurology 1994;44:957-8
   PubMed Web of Science ®Google Scholar
• Kenney C, Hunter C, Jankovic J. Long-term tolerabilty of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 2006;22(2):193-7
   Google Scholar
• Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 1982;11:41-7
   PubMed Web of Science ®Google Scholar
• Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997;48(2):358-62
   PubMedGoogle Scholar
• Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988;38(3):391-4
   PubMedGoogle Scholar
• Pekkenberg H, Fog R. Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both. Arch Neurol 1974;31:352-3
   PubMedGoogle Scholar
• Reches A, Hassan M, Jackson V, Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not of alpha methyl-P-tyrosine. Life Sci 1983;33:157-60
   PubMedGoogle Scholar
• Furukawa T, Ushizima I, Ono N. Modifications by litium of behavioral responses to methamphetamine and tetrabenazine. Psychopharmacologia 1975;42:243-8
   PubMedGoogle Scholar
• Ohara S. Mexiletine in the treatment of spasmodic torticollis. Mov Disord 1998;13(6):934-40
   PubMedGoogle Scholar
• Muller J. Riluzole therapy in cervical dystonia. Mov Disord 2002;17(1):198-200
   PubMedGoogle Scholar
• Couper-Smartt J. Lithium in spasmodic torticollis. Lancet 1973;2:741-2
   PubMedGoogle Scholar
• Koller WC, Biary N. Lithium ineffective in dystonia. Ann Neurol 1983;13:579-80
   PubMedGoogle Scholar
• Isgreen WP. Carbamazepine in torsion dystonia. Adv Neurol 1976;14:411-16
   PubMedGoogle Scholar
• Biary N, Koller W. Effect of alcohol on dystonia. Neurology 1985;35:239-43
   PubMed Web of Science ®Google Scholar
• Lang AE, Riley DE. Tizanidine in cranial dystonia. Clin Neuropharmacol 1992;15:142-7
   PubMedGoogle Scholar
• Fox SH. Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. Mov Disord 2002;17:145-9
   PubMed Web of Science ®Google Scholar
• Dressler D, Adib Saberi F. Botulinum toxin: mechanisms of action. Eur Neurol 2005;53(1):3-9
   PubMedGoogle Scholar
• Simpson DM. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology 2008;70:1699-706
   PubMed Web of Science ®Google Scholar
• Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 1987;37(4):616-23
   PubMedGoogle Scholar
• Blitzer A. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 1989;98(2):93-7
   PubMedGoogle Scholar
• Troung DD. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991;101(6 Pt 1):630-4
   PubMedGoogle Scholar
• Hallett M, Benecke R, Blitzer A, Comella CL. Treatment of focal dystonias with botulinum toxin. Toxicon 2009;54(5):628-33
   Google Scholar
• Pullman S. Approach to the treatment of limb disorders with botulinum toxin a: experience with 187 patients. Arch Neurol 1996;53:617-24
   PubMedGoogle Scholar
• Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 1994;9:213-17
   PubMed Web of Science ®Google Scholar
• Jankovic J, Schwarz K. Ressponse and immunoresistance to botulinum toxin injections. Neurology 1995;45:1743-6
   PubMed Web of Science ®Google Scholar
• Arce CA. Selective denervation in cervical dystonia. In: Stacey MA, editor, Handbook of dystonia. Informa Healthcare USA, Inc.: New York; 2007. p. 381-92
   Google Scholar
• Bertrand CM. Selective peripheral denervation for spasmodic torticollis: surgical technique, results, and observations in 260 cases. Surg Neurol 1993;40:96-103
   PubMed Web of Science ®Google Scholar
• Chen X. Selective denervation and resection of cervical muscles in the treatment of spasmodic torticollis: long-term follow-up results in 207 cases. Stereotact Funct Neurosurg 2000;75(2-3):96-102
   PubMedGoogle Scholar
• Braun V, Richter HP. Selective peripheral denervation for spasmodic torticollis: 13 year experience with 155 patients. J Neurosurg 2002;97:207-12
   PubMed Web of Science ®Google Scholar
• Cohen-Gadol AA, Ahlskog JE, Matsumoto JY, Selective peripheral deneration for the treatment of intractable spasmodic torticollis: experience with 168 patients at the mayo clinic. J Neurosurg 2003;98:1247-54
   PubMed Web of Science ®Google Scholar
• Munchau A. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Brain 2001;124(Pt 4):769-83
   PubMedGoogle Scholar
• Narayan RK, Loubser PG, Jankovic J, Intrathecal baclofen for intractable axial dystonia. Neurology 1991;41:1141-2
   PubMed Web of Science ®Google Scholar
• Ford B. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol 1996;53(12):1241-6
   PubMedGoogle Scholar
• Albright AL, Barry MJ, Shafron DH, Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001;43:652-7
   PubMed Web of Science ®Google Scholar
• Albright AL. Intrathecal baclofen for treatment of dystonia. In: Krauss JK, Jankovic J, Grossman R, editor, Surgery for parkinson's disease and movement disorders. Lippincott Williams &Williams: Philadelphia; 2001. pp. 316-322
   Google Scholar
• Cooper IS. 20-year followup study of the neurosurgical treatment of dysotnia musculorum deformans. Adv Neurol 1976;14:423-52
   PubMedGoogle Scholar
• Yianni J. Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit. Mov Disord 2003;18(4):436-42
   PubMedGoogle Scholar
• Eltahawy HA. Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation. Neurosurgery 2004;54:613-19
   PubMed Web of Science ®Google Scholar
• Vidailhet M, Vercueil L, Houeto JL. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol 2007;6:223-9
   PubMed Web of Science ®Google Scholar
• Vidailhet M. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352:459-67
   PubMed Web of Science ®Google Scholar
• Kupsch A, Benecke R, Muller J. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978-1990
   PubMed Web of Science ®Google Scholar
• Vesper J. Deep brain stimulation of the globus pallidus internus (Gpi) for torsion dystonia: a report of two cases. Acta Neurochir Suppl 2001;79:83-8
   Google Scholar
• Tronnier V, Fogel W. Pallidal stimulation for generalized dystonia: report of 3 cases. J Neurosurg 2000;92:453-6
   PubMed Web of Science ®Google Scholar
• Vercueil L, Pollak P, Fraix V. Deep brain stimulation in the treatment of severe dystonia. J Neurol 2001;248:695-700
   PubMed Web of Science ®Google Scholar
• Katayama M. Chronic stimulation of the globus pallidus internusfor control of primary generalized dystonia. Acta Neurochir Suppl 2003;87:125-8
   PubMedGoogle Scholar
• Zorzi G, Marras C, Nardocci N. Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord 2005;20:1194-200
   PubMed Web of Science ®Google Scholar
• Kumar R. Globus pallidus deep brain stimulation for generalized dystonia: clinical and pet investigation. Neurology 1999;53:871-4
   PubMed Web of Science ®Google Scholar
• Kiss ZH. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 2007;130:2879-86
   PubMed Web of Science ®Google Scholar
• Hung SW, Hamani C, Lozano AM. Long term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology 2007;68:457-9
   PubMed Web of Science ®Google Scholar
• Ostrem JL. Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord 2007;22(13):1885-91
   PubMedGoogle Scholar
• Houser M, Waltz T. Meige syndrome and pallidal deep brain stimulation. Mov Disord 2005;20(9):1203-5
   PubMedGoogle Scholar
• Foote KD, Sanchez JC, Okun MS. Staged deep brain stimulation for refractory craniofacial dystonia with blepharospasm: case report and physiology. Neurosurgery 2005;56(2):E415, discussion E415
   PubMedGoogle Scholar
• Damier P, Thobois S, Witjas T. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry 2007;64:170-6
   PubMed Web of Science ®Google Scholar
• Candia V. Constraint-induced movement therapy for focal hand dystonia in musicians. Lancet 1999;353(9146):42
   PubMedGoogle Scholar
• Priori A. Limb immobilization for the treatment of focal occupational dystonia. Neurology 2001;57(3):405-9
   PubMedGoogle Scholar
• Jankovic J. Can peripheral trauma induce dystonia and other movement disorders? Yes! Mov Disord 2001;16(1):7-12
   PubMedGoogle Scholar